Testosterone therapy, prescription treatment that raises low testosterone, can trigger acne that needs active tracking. Track breakouts, oiliness and safety labs, ask about skin care and dose effects, and verify the diagnosis and follow-up plan.
This checklist serves people using testosterone for male hypogonadism who notice new or worse pimples. It links skin changes to the broader safety checks clinicians follow. Use it to spot patterns early and bring clear questions to visits.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Why testosterone triggers breakouts
- What to verify before starting
- What safety labs to track
- How to track and treat acne
Why testosterone triggers breakouts
Androgen-driven acne reflects faster growth and specialization of sebocytes, the cells that make skin oil. A British Journal of Dermatology review links this shift to more sebum, or skin oil, plus buildup of pore-lining skin called infundibular keratinization. More oil plus sticky pore lining traps material and starts pimples. MedlinePlus lists testosterone among medicines that can trigger acne.
It describes clogged pores where oil and skin cells trap bacteria. Trapped bacteria then provoke pimples or deep painful cysts. The dermatology review points to face, chest, back and shoulders as common sites. Check those areas weekly in good light. Note oiliness, blackheads, tender bumps and cysts separately.
What to verify before starting
The Endocrine Society requires compatible symptoms plus consistently low testosterone before treatment. Confirmation needs at least two separate fasting early-morning blood draws, according to the Endocrine Society guideline.
Use this check before accepting acne as a trade-off. A single low reading does not meet the standard. Two timed fasting results do.
- compatible symptoms recorded
- two fasting early-morning results from different days
- dates, times and values saved
- acne history and alternatives discussed
What safety labs to track
The Endocrine Society calls for hematocrit checks at baseline, at 3 to 6 months, then yearly. Hematocrit measures the share of red blood cells in blood. If it exceeds 54 percent, therapy stops pending evaluation for hypoxia and sleep apnea. Routine follow-up also tracks testosterone levels, PSA and prostate status where appropriate, blood pressure and lipids. An Endocrine Society clinician summary also flags fertility counseling.
The same summary notes therapy lowers sperm production and reduces testicular size. On Feb. 28, 2025, the FDA made class-wide testosterone labeling changes. It removed boxed cardiovascular-risk language after the TRAVERSE trial. It added a blood-pressure warning based on ambulatory-monitoring studies, described in the FDA drug safety announcement.
- hematocrit dates and values
- testosterone, PSA, blood pressure and lipids
- fertility plans and testicular changes
- snoring, breath pauses and unusual flushing
How to track and treat acne
FDA-approved testosterone gel labeling lists acne among the most common side effects. The same labeling lists application-site irritation, higher PSA, higher red-cell count and liver-test changes. Log start date, product, dose, application sites and weekly skin photos. Record lesion count, pain, scarring and what you applied.
Bring the log when you discuss dose, product switch or skin referral. The American Academy of Dermatology 2024 guidelines strongly recommend benzoyl peroxide, topical retinoids such as adapalene, tretinoin, tazarotene and trifarotene, and antibiotics including oral doxycycline, alone or combined, described in the updated acne guidelines. Severe or scarring acne warrants prompt dermatology referral. Bring dated photos and product names so skin and dose decisions use the same record.